DalsnaFinance

Raymond Douglas, MD, PhD, Is First in the Nation to Infuse Newly FDA-Approved Thyroid Eye Disease Treatment, LUMVOA ™ (veligrotug-vvze)

Markets PR Newswire By PR Newswire 16 Jul 2026 16:25 1 min read
Raymond Douglas, MD, PhD, Is First in the Nation to Infuse Newly FDA-Approved Thyroid Eye Disease Treatment, LUMVOA ™ (veligrotug-vvze)

BEVERLY HILLS, Calif., July 16, 2026 /PRNewswire/ -- Raymond Douglas, MD, PhD, a world-renowned thyroid eye disease specialist and oculoplastic surgeon, is the first in the United States to administer LUMVOA ™ (veligrotug-vvze), an infusion therapy for thyroid eye disease (TED), post its...

BEVERLY HILLS, Calif., July 16, 2026 /PRNewswire/ -- Raymond Douglas, MD, PhD, a world-renowned thyroid eye disease specialist and oculoplastic surgeon, is the first in the United States to administer LUMVOA ™ (veligrotug-vvze), an infusion therapy for thyroid eye disease (TED), post its...

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.